DP117 | THE TREATMENT OF TRANSPLANT ELIGIBLE PRIMARY PLASMA CELL LEUKEMIA PATIENTS: AN ITALIAN REAL-LIFE STUDY

Primary plasma cell leukemia (pPCL) is a rare variant of plasma cell malignancy characterized by at least 5% circulating plasma cell (cPC), aggressive behavior and ominous prognosis. Though to the rarity of the disease, the choice of treatment is most based on real world evidence and expert consens...

Full description

Bibliographic Details

Published in:	Haematologica
Main Authors:	G. Barilà, L. Pavan, F. Fazio, C. Liberatore, N. Sgherza, S. Morè, G. Vianello, C. S. Cartia, S. Oliva, M. Gentile, A. Furlan, M. Arangio Febbo, O. Annibali, L. Pettine, B. Rossini, F. Guidotti, S. Vedovato, F. Rezzonico, R. Della Pepa, P. Boggione, D. Derudas, D. Nappi, F. Farina, F. Vassallo, B. Gamberi, S. Mangiacavalli, N. Giuliani, M. Galli, A. Tosetto, E. Zamagni, F. Patriarca, M. Offidani, M. T. Petrucci, R. Zambello, P. Musto
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2025-09-01
Online Access:	https://haematologica.org/article/view/12614